Sort
85,873 grants matching “alzheimers”
Discovery and optimization of ApoE4 correctors for the treatment of Alzheimer's Disease
$877,636Michael Jackson · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2025 · AG
Study of Latinos-Investigation of Neurocognitive Aging (SOL-INCA)
$877,584Hector M Gonzalez · University Of California, San Diego · R01 · FY2018 · AG
Neural mechanisms of gait disturbances as individualized digital biomarker trajectories in preclinical dementia
$877,523Ehsan Adeli · Stanford University · R01 · FY2025 · AG
Epigenome Interactions in Complex Neurogenetic Disorders
$877,497Margaret Elizabeth Ross · Weill Medical Coll Of Cornell Univ · R01 · FY2015 · NS
Regulation mechanism and functional genomics of LINE1 RNA in TDP-43 linked neurodegeneration
$877,436Shuying Sun · Johns Hopkins University · R01 · FY2022 · AG
Core C- Biostatistics and Data Analysis Core
$877,373Adam Christian Naj · University Of Pennsylvania · U54 · FY2025 · AG
Longitudinal At Home Smell Testing to Detect Infection by SARS-CoV-2
$877,287Mark W Albers · Massachusetts General Hospital · U01 · FY2021 · DC
Use of iPSC systems to define roles of microglial TREM2/DAP12 and CR3/DAP12 complexes and their genetic variants in specifying risk for late onset sporadic Alzheimer's disease
$877,246Scott Allen Noggle · New York Stem Cell Foundation · R01 · FY2019 · AG
Use of iPSC systems to define roles of microglial TREM2/DAP12 and CR3/DAP12 complexes and their genetic variants in specifying risk for late onset sporadic Alzheimer's disease
$877,246Scott Allen Noggle · New York Stem Cell Foundation · R01 · FY2021 · AG
Use of iPSC systems to define roles of microglial TREM2/DAP12 and CR3/DAP12 complexes and their genetic variants in specifying risk for late onset sporadic Alzheimer's disease
$877,246Valentina Fossati · New York Stem Cell Foundation · R01 · FY2022 · AG
Use of iPSC systems to define roles of microglial TREM2/DAP12 and CR3/DAP12 complexes and their genetic variants in specifying risk for late onset sporadic Alzheimer's disease
$877,246Scott Allen Noggle · New York Stem Cell Foundation · R01 · FY2020 · AG
Compound repositioning for Alzheimer's Disease using knowledge graphs, insurance claims data, and gene expression complementarity
$877,205Andrew I Su · Scripps Research Institute, The · R01 · FY2024 · AG
Core B - Clinical Core
$877,116David A Wolk · University Of Pennsylvania · P30 · FY2020 · AG
PCPT and SELECT Cohorts: Core Infrastructure Support for Cancer Research
$877,112Catherine M. Tangen · Fred Hutchinson Cancer Center · U01 · FY2022 · CA
Training in the Molecular Biology of Neurodegeneration and Alzheimer's Disease
$877,047Bruce A Yankner · Harvard Medical School · T32 · FY2020 · AG
Lipids in Brain Disease and Neuroinflammation: Animal Models
$876,974Stanley I Rapoport · National Institute On Aging · ZIA · FY2012 · AG
Research Program on Cognition and Neuromodulation Based Interventions (RP-CNBI)
$876,688Benjamin Michael Hampstead · University Of Michigan At Ann Arbor · R35 · FY2022 · AG
Molecular & Behavioral Effects of Low Level Mn Exposure
$876,163Tomas R Guilarte · Columbia University Health Sciences · R01 · FY2011 · ES
Pro-Electrophilic Drugs PEDs for Alzheimer's Disease
$876,156Stuart A Lipton · Scripps Research Institute, The · R56 · FY2021 · AG
ALZHEIMERS DISEASE CORE CENTER
$875,958Northwestern University · P30 · FY2000 · AG
Cell autonomous and non-cell autonomous roles of the GWAS risk factor BIN1 in Alzheimer's disease neuropathology
$875,883Gopal Thinakaran · University Of South Florida · RF1 · FY2016 · AG
ApoE Genotype-Directed Drug Repositioning and Combination Therapy for Alzheimer's Disease
$875,721Yadong Huang · J. David Gladstone Institutes · R01 · FY2017 · AG
Mechanisms of Somatic Mutation in Alzheimer's Disease Using Single Neuron Analysis
$875,677Michael B Miller · Brigham And Women'S Hospital · R01 · FY2025 · AG
Cellular Cofactors, Neuronal Stress & Rescue, Aging & Alzheimer Disease
$875,545Shi Du Yan · University Of Kansas Lawrence · P01 · FY2010 · AG
VITAMIN E TRIAL IN PERSONS WITH DOWN SYNDROME
$875,473Arthur Dalton · Institute For Basic Res In Dev Disabil · R01 · FY2009 · AG